152 related articles for article (PubMed ID: 6096758)
21. Interactions of cholecystokinin and glucose in rat pancreatic islets.
Zawalich W; Takuwa N; Takuwa Y; Diaz VA; Rasmussen H
Diabetes; 1987 Apr; 36(4):426-33. PubMed ID: 3028890
[TBL] [Abstract][Full Text] [Related]
22. Carbohydrates modulate opiate receptor mediated mechanisms during postprandial endocrine function.
Schusdziarra V; Rewes B; Lenz N; Maier V; Pfeiffer EF
Regul Pept; 1983 Nov; 7(3):243-52. PubMed ID: 6141625
[TBL] [Abstract][Full Text] [Related]
23. Central and peripheral control of postprandial pyloric motility by endogenous opiates and cholecystokinin in dogs.
Lopez Y; Fioramonti J; Bueno L
Gastroenterology; 1991 Nov; 101(5):1249-55. PubMed ID: 1936795
[TBL] [Abstract][Full Text] [Related]
24. Defect in pancreatic exocrine and endocrine response to CCK in genetically diabetic OLETF rats.
Tachibana I; Akiyama T; Kanagawa K; Shiohara H; Furumi K; Watanabe N; Otsuki M
Am J Physiol; 1996 Apr; 270(4 Pt 1):G730-7. PubMed ID: 8928805
[TBL] [Abstract][Full Text] [Related]
25. Effects of proglumide on cholecystokinin-8-induced exocrine and endocrine pancreatic responses in conscious sheep.
Mineo H; Iwaki N; Kogishi K; Onaga T; Kato S; Zabielski R
Comp Biochem Physiol A Physiol; 1997 Nov; 118(3):759-64. PubMed ID: 9406447
[TBL] [Abstract][Full Text] [Related]
26. Potentiating effect of secretin on cholecystokinin-stimulated pancreatic secretion in dogs.
Chey WY; Lee KY; Chang TM; Chen YF; Millikan L
Am J Physiol; 1984 Mar; 246(3 Pt 1):G248-52. PubMed ID: 6322594
[TBL] [Abstract][Full Text] [Related]
27. Action of cholecystokinin analogues on exocrine and endocrine rat pancreas.
Otsuki M; Okabayashi Y; Ohki A; Oka T; Fujii M; Nakamura T; Sugiura N; Yanaihara N; Baba S
Am J Physiol; 1986 Apr; 250(4 Pt 1):G405-11. PubMed ID: 2421584
[TBL] [Abstract][Full Text] [Related]
28. Effect of cholecystokinin on the accumulation of inositol phosphates in isolated pancreatic islets.
Florholmen J; Malm D; Vonen B; Burhol PG
Am J Physiol; 1989 Dec; 257(6 Pt 1):G865-70. PubMed ID: 2692460
[TBL] [Abstract][Full Text] [Related]
29. Stimulatory and inhibitory effects of galanin on exocrine and endocrine rat pancreas.
Rünzi M; Müller MK; Schmid P; von Schönfeld J; Goebell H
Pancreas; 1992; 7(6):619-23. PubMed ID: 1280360
[TBL] [Abstract][Full Text] [Related]
30. Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans.
Liddle RA; Rushakoff RJ; Morita ET; Beccaria L; Carter JD; Goldfine ID
J Clin Invest; 1988 Jun; 81(6):1675-81. PubMed ID: 3290250
[TBL] [Abstract][Full Text] [Related]
31. Asperlicin antagonizes stimulatory effects of cholecystokinin on isolated islets.
Zawalich WS; Diaz VA
Am J Physiol; 1987 Mar; 252(3 Pt 1):E370-4. PubMed ID: 3548432
[TBL] [Abstract][Full Text] [Related]
32. Evidence for a role of endogenous opiates in postprandial somatostatin release.
Schusdziarra V; Rewes B; Lenz N; Maier V; Pfeiffer EF
Regul Pept; 1983 Aug; 6(4):355-61. PubMed ID: 6138819
[TBL] [Abstract][Full Text] [Related]
33. Endogenous opioid modulation of pancreatic hormone secretion: studies in dogs.
Levin ER; Yamada T; Levin S; Mills S
Metabolism; 1986 Jan; 35(1):59-63. PubMed ID: 2867455
[TBL] [Abstract][Full Text] [Related]
34. Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8.
Fieseler P; Bridenbaugh S; Nustede R; Martell J; Orskov C; Holst JJ; Nauck MA
Am J Physiol; 1995 May; 268(5 Pt 1):E949-55. PubMed ID: 7762650
[TBL] [Abstract][Full Text] [Related]
35. Effect of naloxone on pancreatic and gastric endocrine function in response to carbohydrate and fat-rich test meals.
Schusdziarra V; Holland A; Maier V; Pfeiffer EF
Peptides; 1984; 5(1):65-71. PubMed ID: 6143305
[TBL] [Abstract][Full Text] [Related]
36. Effects of cholecystokinin octapeptide and carbachol on neonatal insulin secretory dynamics.
Fletcher DJ; Rowley WH; Brinn JE
Regul Pept; 1989; 25(3):287-93. PubMed ID: 2672124
[TBL] [Abstract][Full Text] [Related]
37. Effects of two cholecystokinin variants, CCK-39 and CCK-8, on basal and stimulated insulin secretion.
Ahrén B; Lundquist I
Acta Diabetol Lat; 1981; 18(4):345-56. PubMed ID: 6277122
[TBL] [Abstract][Full Text] [Related]
38. Effects of galanin(1-16) on pancreatic secretion in anesthetized and conscious rats.
Takács T; Hegyi P; Czakó L; Baláspiri L; Lonovics J
Res Exp Med (Berl); 2000 Apr; 199(5):275-83. PubMed ID: 10815756
[TBL] [Abstract][Full Text] [Related]
39. Interaction of gastric inhibitory polypeptide (GIP) and cholecystokinin (CCK-8) with basal and stimulated insulin secretion in mice.
Ahrén B; Hedner P; Lundquist I
Acta Endocrinol (Copenh); 1983 Jan; 102(1):96-102. PubMed ID: 6130663
[TBL] [Abstract][Full Text] [Related]
40. Cholecystokinin and somatostatin modulate the glucose-induced insulin secretion by different mechanisms in pancreatic islets. A study on phospholipase C activity and calcium requirement.
Malm D; Giaever A; Vonen B; Florholmen J
Scand J Clin Lab Invest; 1993 Nov; 53(7):671-6. PubMed ID: 7903820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
